Viewing Study NCT01220258


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2025-12-25 @ 10:10 PM
Study NCT ID: NCT01220258
Status: TERMINATED
Last Update Posted: 2013-12-16
First Post: 2010-10-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module